Expert Insight
How Are You and Your Peers Navigating Pharma Manufacturing in 2026? [Survey]
The pharma manufacturing landscape in 2026 is more volatile than ever. Take part in this benchmarking study to see how your peers are responding. Rapidly changing geopolitics. Capacity constraints. Pricing pressure. Technology disruption. The challenges facing biopharma sponsors and CDMO
6 January 2026